QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: gad.1345006v1 20/5/613    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hallstrom, T. C. Articles by Nevins, J. R. Search for Related Content PubMed PubMed Citation Articles by Hallstrom, T. C. Articles by Nevins, J. R. Social Bookmarking                   What's this?

RESEARCH PAPER

Jab1 is a specificity factor for E2F1-induced apoptosis

Duke Institute for Genome Sciences and Policy Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA

The members of the E2F family of transcription factors are key regulators of genes involved in cell cycle progression, cell fate determination, DNA damage repair, and apoptosis. Many cell-based experiments suggest that E2F1 is a stronger inducer of apoptosis than the other E2Fs. Our previous work identified the E2F1 marked box and flanking region as critical for the specificity in E2F1 apoptosis induction. We have now used a yeast two-hybrid screen to identify proteins that bind the E2F1 marked box and flanking regions, with a potential role in E2F1 apoptosis induction. We identified Jab1 as an E2F1-specific binding protein and showed that Jab1 and E2F1 coexpression synergistically induce apoptosis, coincident with an induction of p53 protein accumulation. In contrast, Jab1 does not synergize with E2F1 to promote cell cycle entry. Cells depleted of Jab1 are deficient for both E2F1-induced apoptosis and induction of p53 accumulation. We suggest that Jab1 is an essential cofactor for the apoptotic function of E2F1.

[Keywords: E2F; Jab1; apoptosis]

Received June 14, 2005; revised version accepted December 28, 2005.

¹ Corresponding author.
E-MAIL j.nevins{at}duke.edu; FAX (919) 681-8973.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. S. Adler, L. E. Littlepage, M. Lin, T. L.A. Kawahara, D. J. Wong, Z. Werb, and H. Y. Chang CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression Cancer Res., January 15, 2008; 68(2): 506 - 515. [Abstract] [Full Text] [PDF]

				Z. Ullah, M. S. Buckley, D. N. Arnosti, and R. W. Henry Retinoblastoma Protein Regulation by the COP9 Signalosome Mol. Biol. Cell, April 1, 2007; 18(4): 1179 - 1186. [Abstract] [Full Text] [PDF]

				D. Ginsberg EGFR Signaling Inhibits E2F1-Induced Apoptosis in Vivo: Implications for Cancer Therapy Sci. Signal., January 30, 2007; 2007(371): pe4 - pe4. [Abstract] [Full Text] [PDF]